Biora Therapeutics, Inc.
OTC: BIOR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Aditya Mohanty
- Employees
- 58
- Headquarters
- San Diego, United States
- IPO year
- 2020
- Market cap
- $995.0K
- Website
- https://www.bioratherapeutics.com
Loading BIOR…
Loading profile data…Frequently asked questions about BIOR
What does Biora Therapeutics, Inc. (BIOR) do?
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestible smart capsule designed to deliver medications precisely within the gastrointestinal (GI) tract....
Where does BIOR trade?
Biora Therapeutics, Inc. (BIOR) trades on the Other OTC.
What sector is BIOR in?
Biora Therapeutics, Inc. (BIOR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biora Therapeutics, Inc.?
Aditya Mohanty is the chief executive officer of Biora Therapeutics, Inc. (BIOR).
Where is Biora Therapeutics, Inc. headquartered?
Biora Therapeutics, Inc. is headquartered in United States.
Does BIOR pay a dividend?
Biora Therapeutics, Inc. (BIOR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOR go public?
Biora Therapeutics, Inc. (BIOR) completed its initial public offering in 2020.